Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Norditropin® and Norditropin® Cartridges: An Open-Label, Randomized, Comparative Safety and Efficacy Trial in Children With Growth Hormone Deficiency

NCT01502124 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01502124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01502124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Norditropin® and Norditropin® Cartridges: An Open-Label, Randomized, Comparative Safety and Efficacy Trial in Children With Growth Hormone Deficiency
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Completed
Start date
May 8, 2001
Completion date
March 5, 2003
Enrollment
78 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency in children, growth hormone disorder